Dual GIP/GLP-1 Receptor Agonists Obesity Drugs Mar..

создал новую статью

1 д - Перевести

Dual GIP/GLP-1 Receptor Agonists Obesity Drugs Market Overview, Growth Analysis, Trends and Forecast By 2032 | #incretin-based therapies anti-obesity peptides dual agonist weight loss drugs GLP-1 and GIP co-agonists

Dual GIP/GLP-1 Receptor Agonists Obesity Drugs Market Overview, Growth Analysis, Trends and Forecast By 2032

The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period

Нравится

Комментарий

1 д - Перевести

Dual GIP/GLP-1 Receptor Agonists Obesity Drugs Market Overview, Growth Analysis, Trends and Forecast By 2032

Язык